Cargando…
Managing Drug Interactions in Cancer Therapy: A Guide for the Advanced Practitioner
Mrs. P is a 30-year-old woman who presented to our bone marrow transplant program with myelodysplastic syndrome (MDS). She received a haploidentical allogeneic stem cell transplant with a conditioning regimen consisting of busulfan and cyclophosphamide. This treatment was followed by post-transplant...
Autores principales: | Campen, Christopher J., Vogel, Wendy H., Shah, Pooja J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167087/ https://www.ncbi.nlm.nih.gov/pubmed/30310722 |
Ejemplares similares
-
The Launch of the Advanced Practitioner Society for Hematology and Oncology (APSHO)
por: Viale, Pamela Hallquist, et al.
Publicado: (2014) -
Integrating Biosimilars Into Oncology Practice: Implications for the Advanced Practitioner
por: Campen, Christopher J.
Publicado: (2017) -
Oncology Advanced Practitioners and Breast Cancer Prevention
por: Vogel, Wendy H., et al.
Publicado: (2020) -
The Oncology Care Model for Advanced Practitioners
por: Vogel, Wendy H.
Publicado: (2017) -
Determination of the Fair Market Value of Oncology Advanced Practitioners
por: Vogel, Wendy H.
Publicado: (2020)